Ketamine, a dissociative anesthetic, has carved itself a spot in the world of mental health care over the past two decades.

S-ketamine, also called esketamine (Spravato), is a nasal spray with FDA approval for treatment-resistant depression and major depressive disorder with suicidal ideation. You must use esketamine ...

The FDA has approved Janssen’s antidepressant nasal spray Spravato ... to treat depression. Ketamine has long been seen as a potential breakthrough in depression treatment, despite safety ...

Treatment-resistant depression complicates care, defying standard treatments, but new therapies are on the horizon, offering hope for more effective treatment options.

Johnson & Johnson's Spravato therapy for treatment-resistant depression ... "This provides further evidence for the use of esketamine nasal spray in this difficult-to-treat population and offers ...

18r12475 U.S. Food and Drug Administration. SPRAVATO™ (esketamine) nasal spray, CIII prescribing information. Kim JW, Suzuki K, Kavalali ET, et al. Ketamine: mechanisms and relevance to treatment of ...

A study led by researchers at Mass General Brigham suggests a nasal spray developed to target neuroinflammation could one day ...

A new study led by researchers at Mass General Brigham suggests a nasal spray developed to target neuroinflammation could one day be an effective treatment for traumatic brain injury (TBI).

Immunomodulation by nasal anti-CD3 mAb represents a novel avenue for treatment of neuroinflammatory and neurodegenerative human diseases. Tiziana Life Sciences is a clinical-stage ...

An unvaccinated child has died from measles in an outbreak in Texas that has grown to include more than 120 cases spanning nine counties, state health officials announced Wednesday.